The utility of ACE in CS was investigated in a cohort of 172 patients, showing that ACE levels were significantly higher in systemic sarcoidosis (SS) than in isolated CS (ACE, 25.8 versus 18.2 U/l, P = 0.041). This evidence concerns the gene ACE and Cowden syndrome 1.